William J. Greenlee, Ph.D.
Bill Greenlee received his B.S. degree in chemistry at The Ohio State University and his Ph.D. degree from Harvard University. He was an NIH Posdoctoral Fellow at Columbia University before joining Merck Research Laboratories in Rahway, New Jersey. At Merck, Bill was a member of the team that discovered Merck’s antihypertensive drugs Vasotec® and Prinivil®. He was promoted to Director in 1989 and to Senior Director, Medicinal Chemistry in 1992.
In 1995, Bill joined Schering-Plough as Senior Director, Cardiovascular and CNS Chemical Research, and was promoted to Vice President in 2002. During 15 years at Schering-Plough, he and his group advanced eleven drug candidates into clinical trials, including Zontivity® for prevention of thrombosis and the beta-secretase inhibitor verubecestat for treatment of Alzheimer’s disease (Phase 3). Following the acquisition of Schering-Plough by Merck in 2009, he served as Chemistry Site Head in Kenilworth, New Jersey until August, 2010. He is now working as an independent medicinal chemistry consultant.
Bill received the Alfred Burger Award in Medicinal Chemistry from the American Chemical Society in 2004 and was inducted into the ACS Medicinal Chemistry Hall of Fame in 2006. He was elected a Fellow of the American Association for the Advancement of Science in 2007 and a Fellow of the ACS in 2009. He is coauthor of over 200 research publications and co-inventor of over 80 U.S. patents.
In 1995, Bill joined Schering-Plough as Senior Director, Cardiovascular and CNS Chemical Research, and was promoted to Vice President in 2002. During 15 years at Schering-Plough, he and his group advanced eleven drug candidates into clinical trials, including Zontivity® for prevention of thrombosis and the beta-secretase inhibitor verubecestat for treatment of Alzheimer’s disease (Phase 3). Following the acquisition of Schering-Plough by Merck in 2009, he served as Chemistry Site Head in Kenilworth, New Jersey until August, 2010. He is now working as an independent medicinal chemistry consultant.
Bill received the Alfred Burger Award in Medicinal Chemistry from the American Chemical Society in 2004 and was inducted into the ACS Medicinal Chemistry Hall of Fame in 2006. He was elected a Fellow of the American Association for the Advancement of Science in 2007 and a Fellow of the ACS in 2009. He is coauthor of over 200 research publications and co-inventor of over 80 U.S. patents.